1
|
Bedlington N, Abifadel M, Beger B, Bourbon M, Bueno H, Ceska R, Cillíková K, Cimická Z, Daccord M, de Beaufort C, Dharmayat KI, Ference BA, Freiberger T, Geanta M, Gidding SS, Grošelj U, Halle M, Johnson N, Novakovic T, Májek O, Pallidis A, Peretti N, Pinto FJ, Ray KK, Rees B, Reeve J, Reiner Ž, Santos RD, Schunkert H, Šikonja J, Sokolovic M, Tokgözoglu L, Vrablík M, Wiegman A, Gutiérrez-Ibarluzea I. The time is now: Achieving FH paediatric screening across Europe - The Prague Declaration. GMS Health Innov Technol 2022; 16:Doc04. [PMID: 36311985 PMCID: PMC9583732 DOI: 10.3205/hta000136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
Abstract
Familial hypercholesterolaemia (FH) is the most common inherited metabolic disorder characterized by high cholesterol and if left untreated leads to premature cardiovascular disease, such as heart attacks. Treatment that begins early in life, particularly in childhood, is highly efficacious in preventing cardiovascular disease and cost-effective, thus early detection of FH is crucial. However, in Europe, less than 10% of people living with FH are diagnosed and even less receive life-saving treatment. The Prague Declaration is a call to action for national and European Union policymakers and decision-makers and a result of the Czech EU Presidency meeting on FH Paediatric Screening (early detection of inherited high cholesterol) at the Czech Senate in Prague on 6th September 2022. It builds on a considerable body of evidence which was discussed at the Technical Meeting under the auspices of the Slovenian EU Presidency in October 2021. The Prague meeting addressed the outstanding barriers to the systematic implementation of FH paediatric screening across Europe. In this article, we present the key points from the Prague meeting and concrete actions needed to move forward.
Collapse
Affiliation(s)
| | - Marianne Abifadel
- Laboratory of Biochemistry & Molecular Therapeutics, Faculty of Pharmacy, Pôle Technologie–Santé, Saint Joseph University of Beirut, Beirut, Lebanon,Laboratory for Vascular Translational Science, Paris Cité University, Paris, France,Sorbonne Paris Nord University, INSERM, Paris, France
| | - Birgit Beger
- European Heart Network, European Alliance for Cardiovascular Health, Brussels, Belgium
| | - Mafalda Bourbon
- Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal,BioISI – Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal
| | - Héctor Bueno
- Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain,Cardiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain,Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain,Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, Madrid, Spain,Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain
| | - Richard Ceska
- 3rd Department of Medicine – Department of Endocrinology & Metabolism of the 1st Faculty of Medicine, Charles University & General University Hospital, Prague, Czech Rep
| | | | | | | | - Carine de Beaufort
- Diabetes & Endocrine Care Clinique Pediatrique/CHL, Luxembourg, Grand Duchy Luxembourg
| | - Kanika I. Dharmayat
- Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London, UK
| | | | - Tomáš Freiberger
- Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Rep,Medical Faculty, Masaryk University, Brno, Czech Rep
| | | | | | - Urh Grošelj
- Department of Endocrinology, Diabetes & Metabolic Diseases, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia,Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| | - Martin Halle
- Department of Prevention & Sports Medicine, University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany,Deutsches Zentrum für Herz-Kreislauf-Forschung, Munich Heart Alliance, Munich, Germany
| | | | | | - Ondrej Májek
- National Screening Centre, Institute of Health Information & Statistics of the Czech Republic, Prague, Czech Rep,Institute of Biostatistics & Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Rep
| | | | - Noel Peretti
- Department of Pediatric Gastroenterology-Hepatology & Nutrition, Hospices Civil de Lyon HCL, Hôpital Femme Mere Enfant HFME, Bron, France,Univ-Lyon, CarMeN laboratory, INSERM U1060, INRAE U1397, Université Claude Bernard Lyon-1, Oullins, Lyon, France
| | - Fausto J. Pinto
- World Heart Federation, Geneva, Switzerland,Cardiovascular Department, CCUL, CAML, Lisbon School of Medicine, University of Lisbon, Lisbon, Portugal
| | - Kausik Kosh Ray
- Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London, UK,European Atherosclerosis Society, Göteborg, Sweden
| | - Bleddyn Rees
- The Digital Health Society, Dublin, Ireland,The European Connected Health Alliance, Belfast, UK
| | | | - Željko Reiner
- University Hospital Center Zagreb, Department for Metabolic Diseases, Zagreb, Croatia
| | - Raul D. Santos
- Lipid Clinic Heart Institute, University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil,Hospital Israelita Albert Einstein, Sao Paulo, Brazil,International Atherosclerosis Society, Milan, Italy
| | | | - Jaka Šikonja
- Department of Endocrinology, Diabetes & Metabolic Diseases, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia
| | | | - Lale Tokgözoglu
- European Atherosclerosis Society, Göteborg, Sweden,Department of Cardiology, Hacettepe University, Ankara, Turkey
| | - Michal Vrablík
- 3rd Department of Internal Medicine, General Teaching Hospital, Prague, Czech Rep,1st Faculty of Medicine, Charles University, Prague, Czech Rep
| | - Albert Wiegman
- University of Amsterdam, Department of Paediatrics, Amsterdam, Netherlands
| | - Iñaki Gutiérrez-Ibarluzea
- Basque Foundation for Health Innovation and Research, Barakaldo, Spain,*To whom correspondence should be addressed: Iñaki Gutiérrez-Ibarluzea, Basque Foundation for Health Innovation and Research (BIOEF), Head of Knowledge Management and HTA, Barakaldo, Spain, E-mail:
| |
Collapse
|
2
|
Murakami N, Tanabe K, Morita T, Fujikawa Y, Koseki S, Kajiura S, Nakajima K, Hayashi R. Process Evaluation of the Regional Referral Clinical Pathway for Home-Based Palliative Care and Outreach Program: A Questionnaire Survey of the Medical Staff and Bereaved Families. Am J Hosp Palliat Care 2021; 39:1029-1038. [PMID: 34872375 PMCID: PMC9386762 DOI: 10.1177/10499091211055901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Background: The purpose of this study was to clarify how the Regional Referral Clinical Pathway for Home-based Palliative Care (RRCP-HPC) and an outreach program by a palliative care team (PCT) lead to an improvement in the outcome. Design and Methods: We conducted questionnaire surveys using the mailing method involving the regional medical staff involved in cancer patients introduced to the PCT of a single hospital, as well as bereaved families. The questionnaire was prepared through interviews with the medical staff and bereaved families. Subsequently, factor analysis was performed to identify factor structures and calculate the correlation coefficient with each outcome. Results: For the questionnaire survey involving the medical staff, responses were collected from 119 regional medical institutions and 84 regional medical staff. The response rate per institution was 51.3%. Similarly, for the questionnaire survey involving bereaved families, the response rate was 42.4%. For the survey involving the medical staff, 6 factors, such as “improved awareness of an interdisciplinary team,” were extracted. For the survey involving the bereaved families, 4 factors, such as “improvement of communications between patients and healthcare professionals,” were extracted. There were significant (≥moderate) correlations between these factors and all outcomes. Conclusion: In this study, we clarified the process of achieving palliative care until death at home without difficulties using the outreach program and RRCP-HPC. The results suggest the importance of improving communications. The outreach program and RRCP-HPC may have contributed to palliative care at home without difficulties through an improvement in communications.
Collapse
Affiliation(s)
- Nozomu Murakami
- Department of Palliative Care Surgery, 13869Kouseiren Takaoka Hospital, Toyama, Japan
| | - Kouichi Tanabe
- Drug Informatics, Faculty of Pharmacy, 12942Meijo University, Aichi, Japan
| | - Tatsuya Morita
- Department of Palliative and Supportive Care, Seirei Mikatahara Hospital, Shizuoka, Japan
| | - Yasunaga Fujikawa
- A Board of Palliative Care, Saiseikai Takaoka Hospital, Toyama, Japan
| | - Shiro Koseki
- Home Palliative Care Committee, Takaoka Medical Service Region, Toyama, Japan
| | - Shinya Kajiura
- Department of Clinical Oncology, 476163Toyama University Hospital, Toyama, Japan
| | - Kazunori Nakajima
- Department of Palliative Care Surgery, 13869Kouseiren Takaoka Hospital, Toyama, Japan
| | - Ryuji Hayashi
- Department of Clinical Oncology, 476163Toyama University Hospital, Toyama, Japan
| |
Collapse
|
4
|
Andersson AM, Opstrup MS, Zachariae C, Friis UF, Thyssen JP, Johansen JD. The importance of a complete declaration of isothiazolinones in products beyond cosmetics. Contact Dermatitis 2018; 77:171-172. [PMID: 28766801 DOI: 10.1111/cod.12755] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2016] [Revised: 12/09/2016] [Accepted: 12/12/2016] [Indexed: 11/30/2022]
Affiliation(s)
- Anna M Andersson
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark
| | - Morten S Opstrup
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.,Department of Dermatology and Allergy, National Allergy Research Centre, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark
| | - Claus Zachariae
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark
| | - Ulrik F Friis
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.,Department of Dermatology and Allergy, National Allergy Research Centre, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark
| | - Jacob P Thyssen
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.,Department of Dermatology and Allergy, National Allergy Research Centre, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark
| | - Jeanne D Johansen
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.,Department of Dermatology and Allergy, National Allergy Research Centre, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark
| |
Collapse
|
6
|
Omrane A, Kreim A, Henchi MA, Kammoun S, Bessadi L, Amri C, Khalfallh T, Bouzgarrou L. [Occupational asthma compensation in the Tunisian Center: cross-sectional study over a period of eight years]. Pan Afr Med J 2017; 26:164. [PMID: 28533885 PMCID: PMC5429451 DOI: 10.11604/pamj.2017.26.164.11486] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2016] [Accepted: 02/18/2017] [Indexed: 11/11/2022] Open
Abstract
INTRODUCTION Our study aimed to highlight the epidemiological profile of patients compensated for occupational asthma in the Tunisian Center, to identify their professional characteristics and to determine compensation practices for this occupational disease. METHODS We conducted an exhaustive retrospective study over a period of eight years. This case study included workers with occupational asthma diagnosed and compensated in the Tunisian Center by the only two medical commissions empowered to set rates for permanent partial disability caused by either a work-related injury or an occupational diseases in the seven central governorates. RESULTS A total of 129 workers, with average age of 40.6 ± 7.75 years were compensated for occupational asthma during the study period. Sex ratio was 0.66. The most incriminated etiologic agents were vegetable dust pollution in the textile industry (75.2%), wood dust, flour and isocyanates. Nonspecific bronchial hyperreactivity was found in 38% of cases, a high rate of IgE in 14% of cases and positive skin prick test in 10.9% of cases. The average rate of permanent partial disability was 25.6 ± 14.2%. On the basis of the analytical study, this rate was related to patient's age and to the medical commission which had set this rate. CONCLUSION This study of workers compensated for occupational asthma provides relevant data about epidemiological and clinical features of diagnosed patients and committee practices in particular, in term of application of the voluntary indicative scale, but it does not allow an assessment of the prevalence of this pathology which is often underestimated.
Collapse
Affiliation(s)
- Amira Omrane
- Département de Médecine de Travail et d'Ergonomie, Faculté de Médecine de Monastir, Monastir, Tunisie
| | - Awatef Kreim
- Département de Médecine de Travail et d'Ergonomie, Faculté de Médecine de Monastir, Monastir, Tunisie
| | - Mohamed Adnène Henchi
- Département de Médecine de Travail et d'Ergonomie, Faculté de Médecine de Monastir, Monastir, Tunisie
| | - Selma Kammoun
- Département de Médecine de Travail et d'Ergonomie, Faculté de Médecine de Monastir, Monastir, Tunisie
| | - Leila Bessadi
- Caisse nationale d'Assurance-maladie de Tunisie, Tunisie
| | - Charfeddine Amri
- Département de Médecine de Travail et d'Ergonomie, Faculté de Médecine de Monastir, Monastir, Tunisie
| | - Taoufik Khalfallh
- Département de Médecine de Travail et d'Ergonomie, Faculté de Médecine de Monastir, Monastir, Tunisie
| | - Lamia Bouzgarrou
- Département de Médecine de Travail et d'Ergonomie, Faculté de Médecine de Monastir, Monastir, Tunisie
| |
Collapse
|
10
|
Downing J, Marston J, Muckaden M, Boucher S, Cardoz M, Nkosi B, Steel B, Talawadekar P, Tilve P. Transforming children's palliative care-from ideas to action: highlights from the first ICPCN conference on children's palliative care. Ecancermedicalscience 2014; 8:415. [PMID: 24761156 PMCID: PMC3971869 DOI: 10.3332/ecancer.2014.415] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2014] [Indexed: 11/21/2022] Open
Abstract
The International Children’s Palliative Care Network (ICPCN) held its first international conference on children’s palliative care, in conjunction with Tata Memorial Centre, in Mumbai, India, from 10–12 February 2014. The theme of the conference, Transforming children’s palliative care—from ideas to action, reflected the vision of the ICPCN to live in a world where every child who needs it, can access palliative care, regardless of where they live. Key to this is action, to develop service provision and advocate for children’s palliative care. Three pre-conference workshops were held on 9 February, aimed at doctors, nurses, social workers, and volunteers, and focused around the principles of children’s palliative care, and in particular pain and symptom management. The conference brought together 235 participants representing 38 countries. Key themes identified throughout the conference included: the need for advocacy and leadership; for education and research, with great strides having been taken in the development of an evidence base for children’s palliative care, along with the provision of education; the importance of communication and attention to spirituality in children, and issues around clinical care, in particular for neonates. Delegates were continually challenged to transform children’s palliative care in their parts of the world and the conference culminated in the signing of the ICPCN Mumbai Declaration. The Declaration calls upon governments around the world to improve access to quality children’s palliative care services and made a call on the Belgian government not to pass a bill allowing children to be euthanised in that country. The conference highlighted many of the ongoing developments in children’s palliative care around the world, and as she closed the conference, Joan Marston (ICPCN CEO) challenged participants to take positive action and be the champions that the children need, thus transforming children’s palliative care.
Collapse
Affiliation(s)
- J Downing
- International Children's Palliative Care Network and Makerere University, PO Box 72518, Kampala, Uganda
| | - J Marston
- ICPCN, Bleomfontein 9301, South Africa
| | - Ma Muckaden
- Department of Palliative Medicine, Tata Memorial Centre, Mumbai, Maharashta 400012, India
| | | | - M Cardoz
- Children's Palliative Care Project, Indian Association of Palliative Care, Mumbai, Maharashta 400012, India
| | - B Nkosi
- ICPCN, Johannesburg 2000, South Africa
| | - B Steel
- ICPCN, Durban 4000, South Africa
| | - P Talawadekar
- Children's Palliative Care Project, Indian Association of Palliative Care, Mumbai, Maharashta 400012, India
| | - P Tilve
- Department of Palliative Medicine, Tata Memorial Centre, Mumbai, Maharashta 400012, India
| |
Collapse
|